Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) - Pipeline Insight, 2020

  • RnM3882149
    • |
  • 14 February, 2020
    • |
  • 106 Pages
    • |
  • DelveInsight
    • |
  • Pharma & Healthcare

Make an enquiry before buying this Report



Purchase this Report

$2,500.00
$5,000.00
$7,500.00
1,977.50
3,955.00
5,932.50
2,305.00
4,610.00
6,915.00
388,250.00
776,500.00
1,164,750.00
208,750.00
417,500.00
626,250.00
Credit card Logo

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo